Corium Launches Innovative ADHD Treatment AZSTARYS(TM) (serdexmethylphenidate and dexmethylphenidate) in the U.S. for Patients Age 6 Years and Older

AZSTARYS is the First and Only Product Containing Prodrug of Dexmethylphenidate Unique formulation provides rapid and extended duration symptom control BOSTON, July 21, 2021 -- (Healthcare Sales & Marketing Network) -- Corium, Inc., a commercial-sta... Biopharmaceutical, Neurology, Product Launch Corium Inc, AZSTARYS, ADHD
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news